CHEBI:141530 - delanzomib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name delanzomib
ChEBI ID CHEBI:141530
Definition A C-terminal boronic acid peptide inhibitor which induces apoptosis in multiple myeloma, hematological and solid tumor cell lines.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Mark Williams
Supplier Information
Download Molfile XML SDF
Formula C21H28BN3O5
Net Charge 0
Average Mass 413.276
Monoisotopic Mass 413.21220
InChI InChI=1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14-,18+,19+/m1/s1
InChIKey SJFBTAPEPRWNKH-CCKFTAQKSA-N
SMILES O=C(N[C@H](C(=O)N[C@@H](CC(C)C)B(O)O)[C@H](O)C)C1=NC(C2=CC=CC=C2)=CC=C1
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): proteasome inhibitor
A drug that blocks the action of proteasomes, cellular complexes that break down proteins.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing delanzomib (CHEBI:141530) has functional parent L-threonine (CHEBI:16857)
delanzomib (CHEBI:141530) has role antineoplastic agent (CHEBI:35610)
delanzomib (CHEBI:141530) has role apoptosis inducer (CHEBI:68495)
delanzomib (CHEBI:141530) has role proteasome inhibitor (CHEBI:52726)
delanzomib (CHEBI:141530) is a C-terminal boronic acid peptide (CHEBI:140517)
delanzomib (CHEBI:141530) is a phenylpyridine (CHEBI:38193)
delanzomib (CHEBI:141530) is a secondary alcohol (CHEBI:35681)
delanzomib (CHEBI:141530) is a threonine derivative (CHEBI:26987)
IUPAC Name
[(1R)-3-methyl-1-({N-[(6-phenylpyridin-2-yl)carbonyl]-L-threonyl}amino)butyl]boronic acid
INNs Sources
délanzomib WHO MedNet
delanzomib WHO MedNet
delanzomibum WHO MedNet
Synonyms Sources
[(1R)-1-[[(2S,3R)-3-hydroxy-1-oxo-2-[[oxo-(6-phenyl-2-pyridyl)methyl]amino]butyl]amino]-3-methylbutyl]boronic acid ChEBI
[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridin-2-yl)carbonylamino]butanoyl]amino]-3-methyl-butyl]boronic acid ChEBI
boronic acid, ((1R)-1-(((2S,3R)-3-hydroxy-1-oxo-2-(((6-phenyl-2-pyridinyl)carbonyl)amino)butyl)amino)-3-methylbutyl)- ChemIDplus
CEP-18770 ChEBI
CT-47098 ChEBI
Manual Xrefs Databases
D10110 KEGG DRUG
DB11956 DrugBank
WO2011087822 Patent
View more database links
Registry Numbers Types Sources
12211043 Reaxys Registry Number Reaxys
847499-27-8 CAS Registry Number ChemIDplus
847499-27-8 CAS Registry Number DrugBank
Citations Waiting for Citations Types Sources
18057228 PubMed citation Europe PMC
19958357 PubMed citation Europe PMC
20872901 PubMed citation Europe PMC
22178195 PubMed citation Europe PMC
22906694 PubMed citation Europe PMC
23058787 PubMed citation Europe PMC
28140719 PubMed citation Europe PMC
29371974 PubMed citation Europe PMC
29848702 PubMed citation Europe PMC
Last Modified
23 August 2018